Oncology dominates CRISPR landscape: GlobalData
Oncology accounts for 30 per cent of all active CRISPR drugs
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Expert Speak | Dr Brijesh Kapil, Global Consumer Healthcare Expert
Express Pharma – Nutrify Today Boardroom Series | EP 17
Opportunities for cell and gene therapy landscape remain high but so does challenges: GlobalData
There are 694 CGTs in development across various therapy areas in the US as of February 2024
Venus Remedies gets first incentive of Rs.7.50 crore under PLl scheme
The disbursement will bolster the company's manufacturing capabilities and foster product diversification, including manufacturing…
Expert Speak | Dr Raktim Chattopadhyay, Founder & CEO, Esperer Nutrition; Member of Task Force,…
Express Pharma – Nutrify Today Boardroom Series | EP 16
Strides gets USFDA approval for Gabapentin Tablets USP, 600 mg and 800 mg
Gabapentin tablets will be manufactured at the company’s facility in Puducherry
ICT Mumbai’s SATHI FOUNDATION (Mumbai Biocluster) gets 60 cr to accelerate biopharma innovation
The fund will be to accelerate the development of critical therapies for diseases like cancer, rare diseases, and infectious…
High ADHD comorbidity rates offer opportunity for pipeline products to capture market: GlobalData
Among the comorbidities associated with ADHD, key opinion leaders (KOLs) interviewed by GlobalData noted anxiety disorder,…
Dr Mansukh Mandaviya inaugurates 27 greenfield bulk drug park projects and 13 medical devices plants…
PLI scheme envisages manufacturing of 41 Bulk Drugs with a total outlay of Rs. 6,940 cr. during the tenure of the scheme from…
Vriddhi 2024, IDMA’s Annual Conference held in FLAME University
The agenda of this event was to examine and assess the opportunities, challenges, and strategic directions of the Indian pharma…